Bgl Announces Growth Equity Investment In Cardioline By Archimed
12/03/21, 7:35 PM
Location
chicagoBrown Gibbons Lang & Company (BGL), a leading investment banking and financial advisory firm, is pleased to announce the closing of the acquisition of a majority stake in Cardioline, a European cardiology diagnostics company and the European leader in cardiology-focused telemedicine, by ArchiMed, a trans-Atlantic private equity firm specializing in healthcare. BGL's Healthcare & Life Sciences team initiated the transaction and acted as the exclusive financial advisor to Cardioline. The specific terms of the transaction were not disclosed.
Company Info
Location
chicago, illinois, united states
Additional Info
The firm advises private and public corporations and private equity groups on mergers and acquisitions, capital markets, financial restructurings, valuations and opinions, and other strategic matters. Founded in 1962 and based in Trento, Italy, Cardioline is one of Europe's most trusted brands for the manufacture and provision of traditional cardiology devices and services. Supplying 20 percent of hospital and 50 percent of physician demand for electrocardiogram machines in Italy, Cardioline is also Europe's largest provider of cardiology-focused telemedicine. Cardioline is the first purchase of ArchiMed's MED III Fund, which closed on €650 million in August 2021, after less than two months of fundraising.